Clinical Trial Update: Methylphenidate, Rivastigmine or Haloperidol in Hypoactive Delirium in Intensive Care Patients [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing methylphenidate, rivastigmine, and haloperidol for hypoactive delirium in intensive care unit patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Drugs mentioned

• HALOPERIDOL (HALOPERIDOL LACTATE)
• Methylphenidate (Methylphenidate)
• Rivastigmine (Rivastigmine)

Snippet

Sponsor: UMC Utrecht | Conditions: Delirium | Phase 3 | Status: TERMINATED